Abstract:Carcinoma of Unknown Primary (CUP) is a subset of metastatic cancers in which the primary tissue source, or origin, remains unidentified. CUP accounts for three to five percent of all malignancies [ ]. Representing an exceptionally aggressive category of metastatic cancers, the median survival of those diagnosed with CUP is approximately three to six months [ ]. The tissue in which a cancer arises plays a key role in our understanding of altered gene expression, altered cellular pathways, and sensitivities to various forms of cell death in cancer cells [ ]. Thus, the lack of knowledge on tissue of origin makes it difficult to devise tailored treatments for patients with CUP [ ]. Developing clinically implementable methods to identify the tissue of origin of the primary site is crucial in treating CUP patients [ ]. In particular, the expression profiles of non-coding RNAs can provide insight into the tissue of origin for CUP. Non-coding RNAs provide a robust route to clinical implementation due to their resistance against chemical degradation [ ]. In this work, we investigate the potential of microRNAs as highly accurate biomarkers for detecting the tissue of origin for metastatic cancers. We further hypothesize that data driven approaches can identify specific microRNA biomarker targets. We used microRNA expression data from the Cancer Genome Atlas (TCGA) dataset [ ] and assessed various machine learning approaches. Our results show that it is possible to design robust classifiers to detect the tissue of origin for metastatic samples on the TCGA dataset with an accuracy of up to 96%, which may be utilized in situations of CUP. As a validation of our classifiers, we evaluated the accuracy on a separate set of 194 primary tumor samples from the Sequence Read Archive (SRA) [ ]. Our findings demonstrate that deep learning techniques enhance prediction accuracy. We progressed from an initial accuracy prediction of 62.5% with decision trees to 93.2% with logistic regression, finally achieving 96.1% accuracy using deep learning on metastatic samples. On the SRA validation set, a lower accuracy of 41.2% was achieved by decision tree, while deep learning achieved a higher accuracy of 81.2%. Notably, our feature importance analysis showed the top three important biomarkers for predicting tissue of origin to be mir-10b, mir-205, and mir-196b, which aligns with previous work [ ]. Our findings highlight the potential of using machine learning techniques to devise tests for detecting tissue of origin for CUP. Since microRNAs are carried throughout the body via vesicles secreted from cells, they may serve as key biomarkers for liquid biopsy due to their presence in blood plasma [ ]. Our work serves as a foundation towards developing blood-based cancer detection tests based on microRNA presence.

A 2-20 GHz high-gain monolithic HEMT distributed amplifier

MiRS-HF: A Novel Deep Learning Predictor for Cancer Classification and miRNA Expression Patterns

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

[Studies on chemical constituents of Curcuma aromatica salisb].

Conductivity of metallic films and multilayers.

Enhancing Lung Cancer Classification and Prediction With Deep Learning and Multi-Omics Data

DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images

Computational genomic algorithms for miRNA-based diagnosis of lung cancer: the potential of machine learning

Constructing a machine learning-based non-invasive liquid biopsy model for lung cancer detection via miRNA sequencing.

Integrating Expression Data-Based Deep Neural Network Models with Biological Networks to Identify Regulatory Modules for Lung Adenocarcinoma

Predicting potential lncRNA biomarkers for lung cancer and neuroblastoma based on an ensemble of a deep neural network and LightGBM

Deep-Learning Algorithm and Concomitant Biomarker Identification for NSCLC Prediction Using Multi-Omics Data Integration

Deep neural network for discovering metabolism-related biomarkers for lung adenocarcinoma

An Innovative Method for Lung Cancer Identification Using Machine Learning Algorithms

MSCS-DeepLN: Evaluating Lung Nodule Malignancy Using Multi-Scale Cost-Sensitive Neural Networks

Deep Learning Based Identification of Tissue of Origin for Carcinomas of Unknown Primary utilizing micro-RNA expression

Deep Learning Empowers Lung Cancer Screening Based on Mobile Low-Dose Computed Tomography in Resource-Constrained Sites

Identification and Validation of Efficacy of Immunological Therapy for Lung Cancer From Histopathological Images Based on Deep Learning

In-depth Bioinformatic Analysis of Lung Cancer-Associated Microrna Targets

A Novel Strategy for Identifying NSCLC MicroRNA Biomarkers and Their Mechanism Analysis Based on a Brand-New CeRNA-Hub-FFL Network

A user-friendly deep learning application for accurate lung cancer diagnosis